Strategies for tolerance induction in nonhuman primates

Current Opinion in Immunology

Volumn 10, Issue 5, 1998, Pages 513-517

  Hamawy, Majed M ^a   Knechtle, Stuart J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOPROTEIN GP 39; IMMUNOSUPPRESSIVE AGENT; IMMUNOTOXIN; MONOCLONAL ANTIBODY CD3; OKT 4; T LYMPHOCYTE RECEPTOR;

BONE MARROW; CHIMERA; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; PRIMATE; SHORT SURVEY; T LYMPHOCYTE;

EID: 0031756735     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80216-1     Document Type: Article

References (26)

1. Geluk A, Elferink DG, Slierendregt BL, Van Meijgaarden KE, De Vries RR, Ottenhoff TH, Bontrop RE. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates. J Exp Med. 177:1993;979-987.
2. Slierendregt BL, Van Noort JT, Bakas RM, Otting N, Jonker M, Bontrop RE. Evolutionary stability of transspecies major histocompatibility complex class II DRB lineages in humans and rhesus monkeys. Hum Immunol. 35:1992;29-39.
3. Jaeger EE, Bontrop RE, Lanchbury JS. Structure, diversity, and evolution of the T-cell receptor VB gene repertoire in primates. Immunogenetics. 40:1994;184-191.
4. Levinson G, Hughes AL, Letvin NL. Sequence and diversity of rhesus monkey T-cell receptor beta chain genes. Immunogenetics. 35:1992;75-88.
5. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JHJ, Knechtle SJ. CTLA4-lg and anti-CD40 ligand prevent renal allograft rejection in primates. of special interest Proc Natl Acad Sci USA. 94:1997;8789-8794 This study showed that costimulation blockade prolongs renal allograft survival in rhesus monkeys. Two animals treated in such a manner experienced late rejection, but a repeat course of the induction regimen successfully restored normal graft function. Unexpectedly, lymphocytes from rejection-free animals responded vigorously in mixed lymphocyte reactions to donor, and to third-party, cells.
6. + cells from the blood and lymph nodes that persisted for three - six months. The IT appears to be safe as there was no evidence of fever, rash, diarrhea or respiratory difficulty after IT injection.
7. Thomas JM, Neville DM, Contreras JL, Eckhoff DE, Meng G, Lobashevsky AL, Wang PX, Huang ZQ, Verbanac KM, Haisch CE, Thomas FT. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. of outstanding interest Transplantation. 64:1997;124-135 Using the rhesus monkey model, this study showed that the combination of day zero infusion of DBM and the immunotoxin prolonged graft survival for at least 120 days. Chimerism was observed in all immunotoxin-treated animals, including those that did not receive DBM; however, the level of chimerism did not correlate with graft survival.
8. Berridge MJ. Lymphocyte activation in health and disease. of special interest Crit Rev Immunol. 17:1997;155-178 This review covers in detail the different aspects of TCR signaling.
9. Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, Laquaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation. 32:1981;535-539.
10. Neville DMJ, Scharff J, Srinivasachar K. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc Natl Acad Sci USA. 89:1992;2585-2589.
11. Knechtle SJ, Fechner SJ, Dong Y, Stavrou S, Neville DM, Oberley T, Buckley P, Armstrong N, Rusterholz K, Hong X, et al. Primate renal transplants using immunotoxin. of special interest Surgery. 124:1998;438-447 Unlike the data presented in [7], this study showed that immunotoxin (diptheria toxin cojugated to anti-CD3 antibody) administered alone, on the day of transplantation, prolonged graft survival in rhesus monkeys. In contrast to the monkeys that received their grafts seven days before transplantation [6], the monkeys in this study rejected their grafts due to chronic rejection.
12. Fechner JHJ, Vargo DJ, Geissler EK, Graeb C, Wang J, Hanaway MJ, Watkins DI, Piekarczyk M, Neville DMJ, Knechtle SJ. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation. 63:1997;1339-1345.
13. Gajewski TF, Qian D, Fields P, Fitch FW. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci USA. 91:1994;38-42.
14. Smith JA, Qizhi T, Bluestone JA. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets. J Immunol. 160:1998;4841-4849.
15. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med. 184:1996;1-8.
16. lck. Cell. 55:1988;301-308.
17. Mourad GJ, Preffer FI, Wee SL, Powelson JA, Kawai T, Delmonico FL, Knowles RW, Cosimi AB, Colvin RB. Humanized lgG1 and lgG4 anti-CD4 monoclonal antibodies-effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation. 65:1998;632-641.
18. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 14:1996;233-258.
19. Lederman S, Yellin MJ, Krichevsky A, Belko J, Lee JJ, Chess L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med. 175:1992;1091-1101.
20. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Mullerberghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. of special interest Nature. 391:1998;591-594 This study demonstrated that CD154 is expressed not only on T cells but also on activated platelets. This finding indicates that the effects of CD154 blockers may not be limited to downregulating T cell function, but that the function of platelets may have also been modulated by these blockers. This suggests that platelets may play an important role in allograft rejection.
21. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:1996;434-438.
22. Krieger NR, Yuh D, McIntyre B, Flavin TF, Yin DP, Robbins R, Fathman CG. Prolongation of cardiac graft survival with anti-CD4 lg plus hCTLA4lg in primates. Surgery. 1998;. in press.
23. Nikolic B, Sykes M. Bone marrow chimerism and transplantation tolerance. Curr Opin Immunol. 9:1997;634-640.
24. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. Modification of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation. 64:1997;709-716.
25. Mychaliska GB, Rice HE, Tarantal AF, Stock PG, Capper J, Garovoy MR, Olson JL, Cowan MJ, Harrison MR. In utero hematopoietic stem cell transplants prolong survival of fetal kidney transplantation in monkeys. of special interest J Pediat Surg. 32:1997;976-981 This study examined the potential for donor bone marrow (BM) transplantation to induce tolerance in utero. T-cell-depleted paternal BM was injected in utero into the peritoneal cavity of two female fetal rhesus monkeys at day 61 of gestation. Chimerism was detected as early as six weeks after birth and until two years of age. In contrast to controls, chimeric monkeys had prolonged graft survival and no clinical evidence of graft failure for at least seven weeks; however, biopsies performed one - four weeks post-transplant showed signs of moderate/acute rejection. Consistent with these in vivo findings, in vitro mixed lymphocyte reactions to the donor cells were reduced compared with responses to third-party cells.
26. Sablinski T, Gianello PR, Bailin M, Bergen KS, Emery DW, Fishman JA, Foley A, Hatch T, Hawley RJ, Kozlowski T, et al. Pig to monkey bone marrow and kidney xenotransplantation. Surgery. 121:1997;381-391.